- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01547494
A Nutritional Intervention for Migraines
May 13, 2013 updated by: Physicians Committee for Responsible Medicine
The purpose of the study is to assess whether, in individuals with migraines, a low-fat, vegan diet improves pain more effectively than a control supplement or a placebo.
The principal measures are pain as measured by Visual Analog Scale (VAS) and the change in migraines frequency.
The study duration is 36 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Preliminary evidence suggests that low-fat, vegetarian diets and certain nutritional supplements can help reduce pain and also reduce the need for pain medications for some people.
We will ask about 100 people to participate.
All of them will get a low-fat, vegan diet and a nutritional supplement (mixture of omega-3 oils and vitamin E or a placebo), although some will get the diet first, and others will get the supplement first.
This order in which they will get the diet and the supplement will be determined randomly, that is, by chance (like the toss of a coin).
The principal measures are pain as measured by Visual Analog Scale (VAS)and the change in migraines frequency.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20016
- Physicians Committee for Responsible Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
A diagnosis of migraine, as defined by the criteria of the second edition of the International Classification of Headache Disorders18
- At least 5 attacks fulfilling criteria the criteria below
- Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)
Headache has at least two of the following characteristics:
- unilateral location
- pulsating quality
- moderate or severe pain intensity
- aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs)
During headache at least one of the following:
- nausea and/or vomiting
- photophobia and phonophobia
- Not attributed to another disorder
- Migraines occurring at least twice per month, on average.
- Age at least 18 years
- Ability and willingness to participate in all components of the study
- Willingness to be assigned to either the diet group or supplement group
- Migraine medications unchanged within last 6 weeks.
Exclusion Criteria:
- < 18 years of age
- Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
- Pregnancy
- Unstable medical or psychiatric illness
- Likely to be disruptive in group sessions (as determined by research staff)
- Already following a low-fat, vegan diet
- Lack of English fluency
- Inability to maintain current medication regimen
- Inability or unwillingness to participate in all components of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Dietary Supplement
|
Vegan diet, which is devoid of animal products and minimal in fat
|
|
EXPERIMENTAL: Vegan Diet
|
mixture of omega3 and vitamins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Migraines Pain Change in Migraines frequency
Time Frame: Baseline and 4 months
|
Pain as measured by VAS score
|
Baseline and 4 months
|
|
Change in Migraines frequency
Time Frame: Baseline and 4 months
|
the reduction in the number of migraine attacks.
|
Baseline and 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: Baseline and 4 months
|
Health related quality of life as measured by a questionnaire
|
Baseline and 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (ACTUAL)
October 1, 2012
Study Completion (ACTUAL)
October 1, 2012
Study Registration Dates
First Submitted
February 27, 2012
First Submitted That Met QC Criteria
March 2, 2012
First Posted (ESTIMATE)
March 7, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
May 14, 2013
Last Update Submitted That Met QC Criteria
May 13, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WCCR-MIG1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraines
-
Trevena Inc.TerminatedMigrainesUnited Kingdom
-
University of MinnesotaCompletedEpilepsy | MigrainesUnited States
-
Barts & The London NHS TrustCompleted
-
Wake Forest University Health SciencesCompleted
-
Physicians Committee for Responsible MedicineCompleted
-
Johns Hopkins UniversityAmerican Regent, Inc.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Duke UniversityCompletedMusculoskeletal Pain | ADHD | Migraines | Pediatric Pain | Childhood Anxiety | Childhood Depression | Pediatric Stomach PainUnited States
Clinical Trials on Vegan Diet
-
University of TorontoCanadian Institutes of Health Research (CIHR); Canadian Diabetes Association; The Physicians' Services Incorporated Foundation and other collaboratorsUnknown
-
University of South CarolinaCompleted
-
Wageningen UniversityRijnstate Hospital; Gelderse Vallei HospitalRecruitingOsteo Arthritis Knee | Protein SynthesisNetherlands
-
Stanford UniversityCompletedInflammation | Glucose Intolerance | Microbiome | Lipid Metabolism | Weight Change, Body | Immune FunctionUnited States
-
Rush University Medical CenterCompletedNutrition Disorders | Risk Reduction | Cardiovascular MorbidityUnited States
-
Physicians Committee for Responsible MedicineRecruiting
-
David Grant U.S. Air Force Medical CenterActive, not recruitingCardiometabolic Risk FactorsUnited States
-
Physicians Committee for Responsible MedicineSibley Memorial HospitalCompleted
-
Wageningen UniversityMaastricht University; RijksoverheidCompleted
-
Maastricht University Medical CenterNational Cattlemen's Beef AssociationRecruitingMuscle Protein Synthetic Response to ProteinNetherlands